What happens after a negative test for tuberculosis? Evaluating adherence to TB diagnostic algorithms in South African primary health clinics

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 5, 2016, Pages e119-e126

  McCarthy, K M ^a,b   Grant, A D ^b,c   Chihota, V ^a,b   Ginindza, S ^a   Mvusi, L ^d   Churchyard, G J ^a,b,c   Fielding, K L ^c  

^a AURUM INSTITUTE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Mortality; TB diagnosis; TB HIV integration; Tuberculosis; Xpert MTB RIF; XTEND

Indexed keywords

ADULT; AGED; ALGORITHM; ANTIVIRAL THERAPY; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIAGNOSTIC TEST; FEMALE; HEALTH CARE PERSONNEL; HEALTH CENTER; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MORTALITY; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOUTH AFRICA; SPUTUM CULTURE; THORAX RADIOGRAPHY; ADOLESCENT; COMPLICATION; DECISION SUPPORT SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; PROCEDURES; PROTOCOL COMPLIANCE; SPUTUM; STANDARDS; SYSTEM ANALYSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGORITHMS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OPERATIONS RESEARCH; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84949471887     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000907     Document Type: Article

References (33)

1. WHO. Global TB Report. Geneva, Switzerland; 2014. Available at: http:// www.who.int/tb/publications/global-report/en/. WHO/HTM/TB/2014.08. Accessed March 12, 2015.
2. Bradshaw D, Pillay-Van Wyk V, Laubscher R, et al. Cause of Death Statistics for South Africa: Challenges and Possibilities for Improvement. Cape Town, South Africa: Burden of Disease Research Unit, Medical Research Council; 2010. Available at: www.mrc.ac.za/bod/cause-death-statsSA.pdf. Accessed March 12, 2015.
3. Wong EB, Omar T, Setlhako GJ, et al. Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS One. 2012;7:e47542.
4. Mortality and causes of death in South Africa, 2013. Findings from Death Notification. Pretoria: Statistics South Africa; 2014. Available at: http:// beta2.statssa.gov.za/publications/P03093/P030932013.pdf. AccessedMarch 12, 2015.
5. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13:349-361.
6. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363: 1005-1015.
7. WHO. Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System for the Diagnosis of Pulmonary and Extra-pulmonary TB in Adults and Children. Policy update. Geneva: WHO; 2013. Available at: http://whqlibdoc.who.int/publications/2011/ 9789241501545-eng.pdf. Accessed March 12, 2015.
8. Keeton C. New diagnostic test changes tuberculosis landscape. Bull World Health Organ. 2013;91:163-164.
9. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229-237.
10. National Department of Health SA. National Tuberculosis Management Guidelines. Tshwane, South Africa: South African National Department of Health; 2014.
11. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4: 97-107.
12. Wood R, Lawn SD, Caldwell J, et al. Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIVstatus. PLoS One. 2011;6:e25098.
13. Churchyard G, Stevens W, Mametja LD, et al. Xpert MTB/RIF replacing sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out. Lancet Glob Health. 2015;3:e450-7.
14. Current Controlled Trials. Xpert for tuberculosis: evaluating a new diagnostic (XTEND). ISRCTN68905568. London: ISRCTN Registry.
15. National Department of Health SA. The diagnosis and management of tuberculosis Pretoria: Department of health, Republic of South Africa. Pretoria: South African National Department of Health; 2009.
16. WHO. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents; Recommendations for HIV-prevalent and resource-constrained settings. Geneva: WHO; 2007.
17. Hayes RJ, Moulton LH. Cluster Randomised Trials. Boca Raton, FL: Chapman & Hall; 2009.
18. Alamo ST, Kunutsor S, Walley J, et al. Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda. Trop Med Int Health. 2012;17:884-895.
19. Walley J, Kunutsor S, Evans M, et al. Validation in Uganda of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings. J Acquir Immune Defic Syndr. 2011;57:e93-100.
20. Holtz TH, Kabera G, Mthiyane T, et al. Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis. 2011;11:533-540.
21. Abebe G, Deribew A, Apers L, et al. Evaluation of the 2007 WHO guideline to diagnose smear negative tuberculosis in an urban hospital in Ethiopia. BMC Infect Dis. 2013;13:427.
22. Dimairo M, MacPherson P, Bandason T, et al. The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe. PLoS One. 2010;5:e11849.
23. Hanrahan CF, Selibas K, Deery CB, et al. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One. 2013;8:e65421.
24. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014;383:424-435.
25. Fielding K, Ginindza S, McCarthy K, et al. High self-reported HIV positive status among clinic attendees suspected of TB enrolled in a cluster randomised trial of Xpert MTB/RIF, South Africa. Paper presented at: Abstract #PC-857-903. 44th Union World Conf Lung Health; 31st 2013; Paris.
26. Macpherson P, Dimairo M, Bandason T, et al. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis. 2011;15:1390-1396.
27. Loveday M, Thomson L, Chopra M, et al. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. Int J Tuberc Lung Dis. 2008;12:1042-1047.
28. Tafuma TA, Burnett RJ, Huis in 't Veld D. National guidelines not always followed when diagnosing smear-negative pulmonary tuberculosis in patients with HIV in Botswana. PLoS One. 2014;9:e88654.
29. Mala G, Moser A, Dinant GJ, et al. Why tuberculosis service providers do not follow treatment guideline in Ethiopia: a qualitative study. J Eval Clin Pract. 2014;20:88-93.
30. Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6:26.
31. Francke AL, Smit MC, de Veer AJ, et al. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38.
32. Nabyonga Orem J, Bataringaya Wavamunno J, Bakeera SK, et al. Do guidelines influence the implementation of health programs? - Uganda's experience. Implement Sci. 2012;7:98.
33. Omar T, Variava E, Lebina L, et al. Post mortem pulmonary pathology in adults dying at home: a study from North West Province. Cape Town, South Africa: IAP; 2012.